Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive medications

Li Tao Zhang1 Department of Urology, Chonbuk National University, Medical School and Biomedical Research Institute and Clinical Trial Center for Medical Devices of Chonbuk National University Hospital, Jeonju, Republic of Korea

Sung Won Lee2 Department of Urology, College of Medicine, Sungkyunkwan University, Seoul, Republic of Korea

Kwangsung Park3 Department of Urology, College of Medicine, Chonnam National University, Gwangju, Republic of Korea

Woo Sik Chung4 Department of Urology, College of Medicine, Ewha Woman’s University, Seoul, Republic of Korea

Sae Woong Kim5 Department of Urology, College of Medicine, Catholic University, Seoul, Republic of Korea

Jae Seog Hyun6 Department of Urology, College of Medicine, Kyungsang National University, Jinju, Republic of Korea

Doo Geon Moon7 Department of Urology, College of Medicine, Korea University, Seoul, Republic of Korea

Sang-Kuk Yang8 Department of Urology, Chungju Hospital, College of Medicine, Konkuk University, Chungju, Republic of Korea

Ji Kan Ryu9 Department of Urology, College of Medicine, Inha University, Incheon, Republic of Korea

Dae Yul Yang10 Department of Urology, College of Medicine, Hallym University, Seoul, Republic of Korea

Ki Hak Moon11 Department of Urology, College of Medicine, Youngnam University, Daegu, Republic of Korea

Kweon Sik Min12 Department of Urology, College of Medicine, Inje University, Busan, Republic of Korea

Jong Kwan Park1 Department of Urology, Chonbuk National University, Medical School and Biomedical Research Institute and Clinical Trial Center for Medical Devices of Chonbuk National University Hospital, Jeonju, Republic of KoreaCorrespondence[email protected]

show all

Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive medications

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive medications

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date